Drugs / extracellular vesicles derived from human induced neural stem cell
extracellular vesicles derived from human induced neural stem cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06612710 | Nov 2025 → Dec 2026 expected | ischemic stroke | Wei Wang | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | extracellular vesicles derived from human induced neural stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06612710 ↗ |
| Modality | Other / unclassified | “human-induced neural stem cell-derived extracellular vesicles (NouvSoma001)” NCT06612710 ↗ |
| Route | Intravenous | “intravenous administration” NCT06612710 ↗ |